Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Will HHS's Appeal Change the Use of Online Trackers in Healthcare?
Regulatory & Compliance Will HHS's Appeal Change the Use of Online Trackers in Healthcare?

The recent decision by the U.S. Department of Health and Human Services (HHS) to appeal a district court ruling on the use of online tracking technologies in healthcare has sent ripples through the industry. This legal battle pits concerns about patient data privacy against the operational needs of

How Are Healthtech Investors Shifting Focus from Growth to Value?
Digital Health How Are Healthtech Investors Shifting Focus from Growth to Value?

The health technology (healthtech) investment landscape is experiencing a profound transformation, driven by evolving economic conditions, investor priorities, and the maturation of the industry itself. What was once a sector characterized by a focus on rapid growth and investment in early-stage

AI and Automation Transform Senior Care with Personalization and Efficiency
Infrastructure & Management AI and Automation Transform Senior Care with Personalization and Efficiency

Artificial Intelligence (AI) and automation are dramatically reshaping the senior care industry, offering unprecedented levels of personalized care and operational efficiency. These technological advancements are not just easing the workload of caregivers but also enhancing the quality of life for

Is Ottobock's Shift from B2B to B2C the Future of Health Tech?
Digital Health Is Ottobock's Shift from B2B to B2C the Future of Health Tech?

Ottobock, a nearly century-old health technology company renowned for its focus on B2B sales channels, is now making a significant shift towards a B2C approach. This pivot is led by Martin Wider, Vice-President of Global Marketing, and is driven by the rise of "educated patients" who are

Medicare's Rising Costs: The Impact of Semaglutide Coverage Analysis
Regulatory & Compliance Medicare's Rising Costs: The Impact of Semaglutide Coverage Analysis

Medicare, the federal health insurance program designed to serve individuals aged 65 and older, faces substantial financial challenges that are growing increasingly severe. Recently, a spotlight has been placed on the potential repercussions of including semaglutide, a high-cost medication

How Is Johns Hopkins Advancing Healthcare AI Through a New Accelerator?
Digital Health How Is Johns Hopkins Advancing Healthcare AI Through a New Accelerator?

The healthcare industry is on the cusp of a significant transformation driven by artificial intelligence (AI), a catalyst for extensive innovation in patient care, diagnostics, and operational efficiency. In this evolving landscape, Johns Hopkins University, in collaboration with CareFirst

J&J's 340B Drug Program Changes Spark Legal and Financial Concerns
Regulatory & Compliance J&J's 340B Drug Program Changes Spark Legal and Financial Concerns

Johnson & Johnson (J&J), one of the leading pharmaceutical companies globally, has announced significant changes to its participation in the 340B drug discount program. Effective October 15, the company will cease providing upfront discounts on two key drugs and move to a rebate system

Epic and Carequality Embrace TEFCA for Seamless Healthcare Data Sharing
Digital Health Epic and Carequality Embrace TEFCA for Seamless Healthcare Data Sharing

In a significant move for the healthcare IT landscape, Epic and Carequality have announced their intentions to align with the Trusted Exchange Framework and Common Agreement (TEFCA). Spearheaded by the 21st Century Cures Act, TEFCA aims to streamline and standardize data sharing across the

Ottobock Transforms Marketing Strategy to Engage Directly with Consumers
Digital Health Ottobock Transforms Marketing Strategy to Engage Directly with Consumers

Ottobock, renowned for its advanced prosthetics, orthotics, and wheelchairs, has long been a titan within the health technology industry. For nearly a hundred years, the company's strategy revolved around B2B (Business-to-Business) channels. During this time, many healthcare providers,

How Do Kids Want to Use Tech for Managing Their Long-Term Conditions?
Digital Health How Do Kids Want to Use Tech for Managing Their Long-Term Conditions?

Long-term conditions (LTCs) such as diabetes, cystic fibrosis, anxiety, depression, and asthma can significantly impact the well-being and everyday life of children and young people. Health technologies have emerged as pivotal tools to assist in managing these conditions, but what exactly do young

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later